PDL BioPharma, Inc.
(NASDAQ : PDLI)

( )
PDLI PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -13.49%265.330.0%$3803.52m
BNTXBioNTech SE -18.67%279.830.0%$1221.54m
NVAXNovavax, Inc. -11.60%141.8678.2%$678.26m
AMGNAmgen, Inc. 3.14%208.791.4%$636.09m
GILDGilead Sciences, Inc. -0.09%69.501.0%$509.20m
LGVNLongeveron Inc. 0.65%20.250.0%$468.87m
VRTXVertex Pharmaceuticals, Inc. 0.61%205.061.9%$451.31m
REGNRegeneron Pharmaceuticals, Inc. -1.60%625.002.7%$399.60m
ILMNIllumina, Inc. 1.26%351.653.3%$324.62m
SNSSSunesis Pharmaceuticals, Inc. 2.68%4.210.7%$294.29m
BIIBBiogen, Inc. 0.09%224.111.8%$281.34m
SGENSeagen Inc. -3.14%146.015.8%$152.04m
INCYIncyte Corp. -1.17%65.012.4%$146.25m
EXASEXACT Sciences Corp. 5.55%80.8418.0%$141.11m
BMRNBioMarin Pharmaceutical, Inc. 1.56%84.244.2%$134.04m

Company Profile

PDL BioPharma, Inc. engages in intellectual property asset management, and patent portfolio and related assets investment activities. Intellectual Property Patents The company has been issued patents in the United States and elsewhere, covering the humanization of antibodies, which are referred to as its Queen et al. patents.The company was founded as a Delaware corporation in 1986 under the name Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006.